Source: XTEK
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

“Yes I am ok.”

This was how former HighCom (ASX:HCL) CEO Scott Basham ended his post on LinkedIn this afternoon, confirming word from HCL not too earlier he’d resigned – effective immediately.

Just yesterday, the company released guidance for its half-year report, stating Directors will take a pay cut for the time being. Uh oh.

“I’ll be taking a break with family and friends for a little while before reaching out to my network in due course to see what other exciting opportunities might be out there … to grow another great company with loads of potential too!” Mr Basham wrote.

Shareholders, clearly, aren’t feeling as positive.

HCL – an ASX-listed defence stock designing next-gen body armour for sale into global military and police markets (formerly XTEK) – has seen its share price sink 46.8 per cent to 17 cents heading into the last hour of trade.

One needn’t be a share market detective to figure out there are two different realities at play here: the one Mr Basham wants to promote, and that HCL wants to promote.

HighCom’s announcement regarding Basham’s exit included (as a headline key point) that HCL will now conduct a “company-wide review” and that “cost-cutting initiatives are underway”.

Poor financial performance clearly the issue

Reading between the lines, one can only assume that Mr Basham made way as a result of the company’s poor financial performance.

And there’s no shortage of data to back that up.

The company posted a net loss of up to $15 million in its guidance release yesterday, a pay cut for C-Suiters, and a wind-back of “costs” at its various operating sites.

That includes former Defence Minister Christopher Pyne.

Mr Basham made $700,000 in 2023; down from $800,000 the year prior.

Meanwhile, one-year returns are down 74.6 per cent; and the stock never returned to its all-time high of 91.3 cents hit in late 2019.

HCL’s share price has had a few runs at it since, but has generally tracked between the 60-cent and 30-cent mark, while taking in rather small orders the entire time, despite promising defence relationships (see: Christopher Pyne).

Forlorn tone

Mr Basham’s LinkedIn post was an interesting one.

Not only did he need to tell us “Yes I am ok,” but at one point, it sounded forlorn – “It’s been a tremendous privilege to lead and work with such a great group of people,” he wrote.

“I will miss them all, as I will miss our great partners, suppliers, customers and industry colleagues.”

Replacing Mr Basham, sort of, will be the new Executive Chairman, Mark Stevens.

But each division of HCL for now will be looked after by its respective and already-in-place division heads.

“The Board would like to acknowledge and thank Mr. Basham for his efforts in the change and transformation of the business since joining the Company in 2021,” HCL’s announcement read, signed off by now-Executive Chairman Mark Stevens.

HCL by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Bourse finishes week on a high as Wisetech pummeled | November 22, 2024

The ASX200 closed up 0.85% at 8,393 points. Economists increasingly expect interest rates in Australia won’t…
The Market Online Video

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing,…
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…